Correlation Between Pulmatrix and Tenax Therapeutics

Can any of the company-specific risk be diversified away by investing in both Pulmatrix and Tenax Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pulmatrix and Tenax Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pulmatrix and Tenax Therapeutics, you can compare the effects of market volatilities on Pulmatrix and Tenax Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pulmatrix with a short position of Tenax Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pulmatrix and Tenax Therapeutics.

Diversification Opportunities for Pulmatrix and Tenax Therapeutics

0.71

Correlation Coefficient

Pulmatrix  Tenax Therapeutics

Poor diversification

The 3 months correlation between Pulmatrix and Tenax is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and Tenax Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tenax Therapeutics and Pulmatrix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pulmatrix are associated (or correlated) with Tenax Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tenax Therapeutics has no effect on the direction of Pulmatrix i.e., Pulmatrix and Tenax Therapeutics go up and down completely randomly.

Pair Corralation between Pulmatrix and Tenax Therapeutics

Given the investment horizon of 90 days Pulmatrix is expected to generate 7.24 times more return on investment than Tenax Therapeutics. However, Pulmatrix is 7.24 times more volatile than Tenax Therapeutics. It trades about 0.33 of its potential returns per unit of risk. Tenax Therapeutics is currently generating about 0.52 per unit of risk. If you would invest  208.00  in Pulmatrix on September 5, 2024 and sell it today you would earn a total of  414.00  from holding Pulmatrix or generate 199.04% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Pulmatrix  vs.  Tenax Therapeutics

Pulmatrix

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Pulmatrix are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Pulmatrix displayed solid returns over the last few months and may actually be approaching a breakup point.

Tenax Therapeutics

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Tenax Therapeutics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Tenax Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pulmatrix and Tenax Therapeutics

The main advantage of trading using opposite Pulmatrix and Tenax Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pulmatrix position performs unexpectedly, Tenax Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tenax Therapeutics will offset losses from the drop in Tenax Therapeutics' long position.

The idea behind Pulmatrix and Tenax Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.